Richlink High-Tech Investment Trust invested project 4DMedical Limited (ASX: 4DX) was successfully listed on the ASX on August 7, 2020. Thanks to the current market demand for leading lung breathing technology, 4DX has gained extremely high exposure and attention in the IPO round. The stock trading volume reached 36 million shares on the day of the issuance, and the opening price had exceeded 1.4 Australian dollars per share, and finally closed at 1.59 Australian dollars per share on the day.
In this IPO, 4DX issued a total of 76,429,701 new shares at 0.73 Australian dollars per share. The fund-raising size reached 55.79 million Australian dollars. After the fund-raising, the company’s market value reached 1932.8 million Australian dollars. Many internationally investment institutions such as Perennial Value Management, Ryder Capital, Pendal Group, EFM Asset Management, OC Funds Management and Quest Asset Partners have been participated.